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The reaction of 3-aryl-2-methyl-quinazolin-4-ones 1
with acidified nitrofurfuraldehyde diacetate 2 in the
presence of piperidine affords 3-aryl-2-[(5-nitro-2-
furyl)vinyl]quinazolin-4-ones 3 in 50-80% yield. These
compounds have been characterized by nitrogen analy-
sis, and IR, IH NMR and mass spectral data. The newly
synthesized compounds have been screened for their
antibacterial activities.
Quinazolinone derivatives exhibit a wide range of
antiparkinson', antibacterial', anthelmintic", CNS
d 3· b I 4 I . 5 .. f1epressant , antitu ercu ar , ana gesic ,antlln am-
matory", hypoglycemic", non-steroidal" and fungi-
cidal activities. The 4(3H)-quinazolinone9 moiety
constitutes an important structural feature in sev-
eral useful sedatives, hypnotic and anticonvulsant
drugs such as Methaqualone and Mecloqualone.
Further, nitrofuran derivatives are being used as
. I h h . 10-11 I . fpotentia c emot erapeutic agents . n view 0
these observations and in continuation of our stud-
ies on chemotherapeutically important nitrofu-
ransI2-14, it was thought of interest to synthesize
novel 3-aryl-2-[(5-nitro-2-furyl)vinyl]-quinazolin-
4-ones 3.
For the present work, various anilines were con-
densed with 2-methyl-3,I-benzoxazin-4-one in the
presence of phosphorus oxychloride employing
toluene as solvent. Such condensations afforded 3-
aryl-2-methyl-quinazolin-4-ones 1 in 60-70%
yield. The required 2-methyl-3,1-benzoxazin-4-one
was prepared by the cyclization of anthranilic acid
with acetic anhydride. Quinazolinones 1 were
characterized by their melting points and reference
to Iiterature I5. 3-Aryl-2-methylquinazolin-4-ones 1
were then condensed with acidified nitrofurfural-
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Scheme I
piperidine to yield 3 (Scheme I). Nitrofurfuralde-
hyde diacetate 2, required for this reaction, was
obtained by the literature method": Characteriza-
tion and spectral data of compounds 3 are given in
Table I.
Antibacterial Activity. All the newly synthe-
sized compounds were screened for their antibacte-
rial activity against Bacillus subtilis, Staphylococ-
cus aureus, Escherichia coli and Pseudomonas
aeruginosa. All of them showed antibacterial ac-
tivity at 5 J..Lg/mLto a lesser degree than that of Fu-
racin, a standard drug used for comparison.
Experimental Section
General. Melting points were determined in
open capillaries and are uncorrected. IR spectra
were recorded on a Shimadzu FT-IR 157 infrared
spectrophotometer, IH NMR spectra in DMSO-d6
on a 90 MHz Perkin-Elmer R-32 instrument using
TMS as internal reference (chemical shifts in 8,
ppm) and mass spectra on a Jeol JMS-D 300 mass
spectrometer.
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Table !-Characterization data of 3-aryl-2-[(5-nitro-2-furyl)vinyl]quinozolin-4-ones 3*
Compd R Yield m.p. Nature of the compound Mol. Formula
(%) °C
ja H 80 254 Orange yellow crystals C2oH13N)O)
3b p-Bromot 81 229 Yellow crystals C20HI2BrN)O)
3c p-Methyl 78 213 Orange crystals C2IH1SN)O)
3d m-Chloro 57 231 Yellowish shining needles C2oHI2CIN)O)
3e 3-Chloro-4-tluorot 81 196 Yellow crystals C2oH11CIFN)O)
3f o-Methoxy 51 191 Light yellow crystals C2IH1SN)04
3~ m-Methyl 68 197 Yellow crystals C2IH1SN)O)
3h p-Nitro 50 242 Brownish orange crystals C2oHI2N40s
31 2.5-Dichloro 53 226 Light yellow crystals C2oHIICI2N)O)
*Satisfactory elemental analyses (±0.3%) were obtained.
tIR: 1675 (C=O), 1600 (C=C), 1550 and 1340 em"! (N02 asym and sym)
tIR: 1681 (C=O), 1600 (C=C), 1545 and 1340 cm-I (N02 asym and sym)
3-Aryl-2-[(5-nitro-2-furyl)vinyl] quinazolin-4-
ones 3: General procedure. An equimolecular
mixture of suitably substituted quinazolinone 1
(0.0 1 mole) and 5-nitro-2-furfuraldehyde diacetate
(2.43 g, 0.01 mole) in absolute ethanol (20 mL)
was treated first with cone. sulphuric acid (0.5 mL)
followed by the addition of piperidine (10 mL).
The mixture was heated under reflux for 1-2 hr. On
cooling the reaction mixture, the resultant product
was filtered, washed and recrystallized from di-
methylformamide. The characterization data of
compounds 3 are given in Table I.
As a representative case the spectral data of 3c
are given below: IR: 1680 (C=O), 1600 (C=C),
1540 and 1340 cm' (N02 asym and sym). IH NMR
(DMSO-d6): 3c 0 2.5 (s, 3H, p-tolyl protons), 6.5-
6.7 (d, 2H, vinyl protons), 7.1-7.4 (m, 8H, aromatic
protons), 7.7-7.9 (d, 2H, furan protons). MS: mlz
359 (~), 313 (M-N02).
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